At the news
? NEUTRALIMPACT 2/10 144 filed Nov 2, 2026 at 16:13 ET
Director George L. Sing filed a Form 144 notice of intent to sell 21,129 shares of Regeneron common stock, with an approximate market value of $20.4 million based on the filing. The shares to be sold were acquired through option exercises, some recent and some previously exercised. This is a routine insider sale filing by a director and does not indicate a change in company fundamentals.
- George L. Sing, a director of Regeneron, filed a Form 144 on November 2, 2026.
- The filing covers the proposed sale of 21,129 shares of common stock.
- The approximate market value of the proposed sale is $20,376,359.76.
- The shares were acquired through exercise of options under a registered plan and previously exercised options.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access